Back

Influence of sacubitril/valsartan on hibernating myocardium in patients with chronic heart failure with reduced ejection fraction

23 May 2022 (08:30 - 18:50)
Organised by:
Congress Presentation Part of: ePoster session 4 Treatment ACNAP Premium Access ACNAP-EuroHeartCare 2022

About the speaker

Photo
Doctor Muyassar Mukhamedova

CENTER FOR THE DEVELOPMENT OF PROFESSIONAL QUALIFICATION OF MEDICAL WORKERS, Tashkent (Uzbekistan)

17 More presentations in this session

Presentation thumbnail
How do Heart Failure Caregivers gain information and support for their role? The contribution of specialist nurses.
Doctor S. Schutz (Oxford, GB)
Abstract Slides
Presentation thumbnail
Non-introduction or withdrawal of prognostic-modifying drugs in HF with reduced ejection fraction
Miss C. Maciel (Penafiel, PT)
Abstract Slides
Presentation thumbnail
Effectiveness of nurse-led self-care interventions on self-care behaviours, self-efficacy, depression, and illness perceptions in people with heart failure: a meta-analysis
Mr Z. Huang (Hong Kong, CN)
Abstract Slides
Presentation thumbnail
Soluble ST2 and nutritional status in patients hospitalized with heart failure with reduced ejection fraction - pilot study
Mr F. Wasniewski (Poznan, PL)
Abstract Slides
Presentation thumbnail
Depressive symptoms are mediating the relationship between non-cardiac comorbidities and self-care of heart failure
Associate Professor K. Lee (Seoul, KR)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 4

The Event

Event poster

ACNAP-EuroHeartCare 2022

23 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources